| P50 | author | Hideki Ebihara | Q54008242 |
| | Eric C Dunham | Q55464663 |
| | Heinz Feldmann | Q60059378 |
| | Thomas Hoenen | Q37378587 |
| P2093 | author name string | Sonja M Best | |
| | Allison Groseth | |
| | Abhilash I Chiramel | |
| | Logan Banadyga | |
| P2860 | cites work | The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo | Q21131393 |
| | 1918 Influenza: the mother of all pandemics | Q22305649 |
| | Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak | Q23000449 |
| | Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome | Q24310145 |
| | Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1 | Q24318342 |
| | Ebola haemorrhagic fever | Q24629338 |
| | Emergence of Zaire Ebola Virus Disease in Guinea | Q25197990 |
| | The evolution and genetics of virus host shifts | Q27004307 |
| | Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist | Q27472136 |
| | Structure of the Ebola VP35 interferon inhibitory domain | Q27653329 |
| | Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs | Q27658947 |
| | Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35 | Q27659023 |
| | The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold | Q27677595 |
| | The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway | Q27682227 |
| | Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 |
| | Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections | Q28248431 |
| | Myxomatosis in Australia and Europe: a model for emerging infectious diseases | Q28259735 |
| | Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling | Q33558506 |
| | Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems | Q33653597 |
| | The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import. | Q34222991 |
| | A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity | Q34262347 |
| | Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses | Q34266468 |
| | Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. | Q34300832 |
| | Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence | Q34434866 |
| | The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. | Q34457606 |
| | Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling | Q34648134 |
| | Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation | Q34648461 |
| | Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. | Q34717930 |
| | Complete genome sequences of three ebola virus isolates from the 2014 outbreak in west Africa | Q34737428 |
| | The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. | Q35105093 |
| | The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase | Q35299892 |
| | Antiviral innate immunity pathways. | Q36394971 |
| | Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses | Q36650409 |
| | Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes | Q36788332 |
| | The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains | Q36978855 |
| | Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8 | Q37232776 |
| | Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain | Q37333731 |
| | Evasion of interferon responses by Ebola and Marburg viruses | Q37582945 |
| | Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. | Q38287391 |
| | The role of oligomerization for the biological functions of the arenavirus nucleoprotein | Q39171988 |
| | Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function | Q39671255 |
| | Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription | Q39707380 |
| | Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis. | Q39796673 |
| | Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome | Q40042116 |
| | Regions in Ebola virus VP24 that are important for nucleocapsid formation | Q40042130 |
| | Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone | Q40156229 |
| | Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences | Q40163432 |
| | The ebolavirus VP24 interferon antagonist: know your enemy | Q40271104 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Orthoebolavirus zairense | Q10538943 |
| P304 | page(s) | 8000 | |
| P577 | publication date | 2015-08-05 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses | |
| P478 | volume | 6 | |